Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0528 Transporter Info
Gene Name	SCN8A
Transporter Name	Voltage-gated sodium channel alpha Nav1.6
Gene ID	6334
UniProt ID	O95788

Post-Translational Modification of This DT
Overview of SCN8A Modification Sites with Functional and Structural Information
Sequence	M A A R L L A P P G P D S F K P F T P E S L A N I E R R I A E S K L K K P P K A D G S H R E D D E D S K P K P N S D L E A G K S L P F I Y G D I P Q G L V A V P L E D F D P Y Y L T Q K T F V V L N R G K T L F R F S A T P A L Y I L S P F N L I R R I A I K I L I H S V F S M I I M C T I L T N C V F M T F S N P P D W S K N V E Y T F T G I Y T F E S L V K I I A R G F C I D G F T F L R D P W N W L D F S V I M M A Y I T E F V N L G N V S A L R T F R V L R A L K T I S V I P G L K T I V G A L I Q S V K K L S D V M I L T V F C L S V F A L I G L Q L F M G N L R N K C V V W P I N F N E S Y L E N G T K G F D W E E Y I N N K T N F Y T V P G M L E P L L C G N S S D A G Q C P E G Y Q C M K A G R N P N Y G Y T S F D T F S W A F L A L F R L M T Q D Y W E N L Y Q L T L R A A G K T Y M I F F V L V I F V G S F Y L V N L I L A V V A M A Y E E Q N Q A T L E E A E Q K E A E F K A M L E Q L K K Q Q E E A Q A A A M A T S A G T V S E D A I E E E G E E G G G S P R S S S E I S K L S S K S A K E R R N R R K K R K Q K E L S E G E E K G D P E K V F K S E S E D G M R R K A F R L P D N R I G R K F S I M N Q S L L S I P G S P F L S R H N S K S S I F S F R G P G R F R D P G S E N E F A D D E H S T V E E S E G R R D S L F I P I R A R E R R S S Y S G Y S G Y S Q G S R S S R I F P S L R R S V K R N S T V D C N G V V S L I G G P G S H I G G R L L P E A T T E V E I K K K G P G S L L V S M D Q L A S Y G R K D R I N S I M S V V T N T L V E E L E E S Q R K C P P C W Y K F A N T F L I W E C H P Y W I K L K E I V N L I V M D P F V D L A I T I C I V L N T L F M A M E H H P M T P Q F E H V L A V G N L V F T G I F T A E M F L K L I A M D P Y Y Y F Q E G W N I F D G F I V S L S L M E L S L A D V E G L S V L R S F R L L R V F K L A K S W P T L N M L I K I I G N S V G A L G N L T L V L A I I V F I F A V V G M Q L F G K S Y K E C V C K I N Q D C E L P R W H M H D F F H S F L I V F R V L C G E W I E T M W D C M E V A G Q A M C L I V F M M V M V I G N L V V L N L F L A L L L S S F S A D N L A A T D D D G E M N N L Q I S V I R I K K G V A W T K L K V H A F M Q A H F K Q R E A D E V K P L D E L Y E K K A N C I A N H T G A D I H R N G D F Q K N G N G T T S G I G S S V E K Y I I D E D H M S F I N N P N L T V R V P I A V G E S D F E N L N T E D V S S E S D P E G S K D K L D D T S S S E G S T I D I K P E V E E V P V E Q P E E Y L D P D A C F T E G C V Q R F K C C Q V N I E E G L G K S W W I L R K T C F L I V E H N W F E T F I I F M I L L S S G A L A F E D I Y I E Q R K T I R T I L E Y A D K V F T Y I F I L E M L L K W T A Y G F V K F F T N A W C W L D F L I V A V S L V S L I A N A L G Y S E L G A I K S L R T L R A L R P L R A L S R F E G M R V V V N A L V G A I P S I M N V L L V C L I F W L I F S I M G V N L F A G K Y H Y C F N E T S E I R F E I E D V N N K T E C E K L M E G N N T E I R W K N V K I N F D N V G A G Y L A L L Q V A T F K G W M D I M Y A A V D S R K P D E Q P K Y E D N I Y M Y I Y F V I F I I F G S F F T L N L F I G V I I D N F N Q Q K K K F G G Q D I F M T E E Q K K Y Y N A M K K L G S K K P Q K P I P R P L N K I Q G I V F D F V T Q Q A F D I V I M M L I C L N M V T M M V E T D T Q S K Q M E N I L Y W I N L V F V I F F T C E C V L K M F A L R H Y Y F T I G W N I F D F V V V I L S I V G M F L A D I I E K Y F V S P T L F R V I R L A R I G R I L R L I K G A K G I R T L L F A L M M S L P A L F N I G L L L F L V M F I F S I F G M S N F A Y V K H E A G I D D M F N F E T F G N S M I C L F Q I T T S A G W D G L L L P I L N R P P D C S L D K E H P G S G F K G D C G N P S V G I F F F V S Y I I I S F L I V V N M Y I A I I L E N F S V A T E E S A D P L S E D D F E T F Y E I W E K F D P D A T Q F I E Y C K L A D F A D A L E H P L R V P K P N T I E L I A M D L P M V S G D R I H C L D I L F A F T K R V L G D S G E L D I L R Q Q M E E R F V A S N P S K V S Y E P I T T T L R R K Q E E V S A V V L Q R A Y R G H L A R R G F I C K K T T S N K L E N G G T H R E K K E S T P S T A S L P S Y D S V T K P E K E K Q Q R A E E G R R E R A K R Q K E V R E S K C
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN8A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN8A Lysine 1487 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	215
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 215 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	289
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 289 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 295 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 308 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 326 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1358
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 1358 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1372
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 1372 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN8A			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1383
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN8A Asparagine 1383 has the potential to affect its expression or activity.
Phosphorylation
Serine	26 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enables further NaV1.6 ubiquitination and internalisation of the channel			[3]
Role of PTM	Crosstalk with Other PTMs
Modified Residue	Serine	Modified Location	553
Related Enzyme	Mitogen-activated protein kinase 1 (MAPK1) E3 ubiquitin-protein ligase NEDD4-like (NEDD4L)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Cross-regulation between Phosphorylation and Ubiquitination at SCN8A Serine 553 have been reported to enable internalisation of the channel.
PTM Phenomenon 2	Slowing the inactivation of sodium channels and reducing peak sodium currents			[4]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	1497
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1497 have been reported to slow the inactivation of sodium channels and reducing peak sodium currents.
PTM Phenomenon 3	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	57
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 57 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN8A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	478
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 478 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN8A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	481
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 481 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN8A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 484 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN8A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	485
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 485 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN8A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 487 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN8A			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	567
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 567 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	612
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 612 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	613
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 613 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	615
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 615 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	618
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 618 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	621
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 621 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	624
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 624 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SCN8A			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	690
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 690 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SCN8A			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	841
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 841 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SCN8A			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1000
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1000 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1068
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1068 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1072
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1072 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SCN8A			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1612
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1612 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1937
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1937 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1940
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1940 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1943
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1943 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1946
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1946 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1949
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Serine 1949 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	90
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 90 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1067
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 1067 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN8A			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1614
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 1614 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1938
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 1938 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1941
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 1941 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1951
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Threonine 1951 has the potential to affect its expression or activity.
Tyrosine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN8A			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 87 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	614
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 614 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	617
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 617 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN8A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	620
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 620 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN8A			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1488
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 1488 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN8A			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 1489 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN8A			[13]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1947
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN8A Tyrosine 1947 has the potential to affect its expression or activity.
Ubiquitination
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enables further NaV1.6 ubiquitination and internalisation of the channel			[3]
Role of PTM	Crosstalk with Other PTMs
Related Enzyme	E3 ubiquitin-protein ligase NEDD4-like (NEDD4L)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Cross-regulation between Phosphorylation and Ubiquitination at SCN8A Serine 553 have been reported to enable internalisation of the channel.

References
1	Prevalence of nonmedical use and routes of administration for prescription stimulant medications among adults in a substance abuse treatment population. J Addict Dis. 2018 Jan-Jun;37(1-2):34-45.
2	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SCN8A_HUMAN)
3	Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK. J Biol Chem. 2010 Aug 20;285(34):26149-61.
4	UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: O95788)
5	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
7	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8	Characterization of the Phosphoproteome in SLE Patients. PLoS One. 2012;7(12):e53129.
9	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
10	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
11	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
12	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
13	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
14	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
15	Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
16	Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res. 2005 May 13;96(9):991-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence